Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 2/1/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Kevin Starr?

Kevin P. Starr

Chief Operating Officer and Chief Financial Officer

Millennium Pharmaceuticals , Inc.

HQ Phone:  (617) 679-7000

Direct Phone: (617) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Millennium Pharmaceuticals , Inc.

40 Landsdowne Street

Cambridge, Massachusetts,02139

United States

Company Description

Millennium: The Takeda Oncology Company , a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor in the US, and has a robust clinical development pipeline of global product candidates. Millennium Pharmaceut...more

Background Information

Employment History

Partner

Third Rock Ventures LLC


Various Executive Roles

Biogen Idec Inc.


Board Member, Interim Chief Executive Officer

Ember Therapeutics Inc


Director

Vitae Pharmaceuticals , Inc.


Affiliations

Alnylam Pharmaceuticals , Inc.

Board Member


AGIOS PHARMACEUTICALS INC

Board Member


ZAFGEN, INC.

Board Member


Afferent Pharmaceuticals Inc

Board Member


PanOptica Inc

Board Member


Sage Therapeutics, Inc.

Chief Executive Officer


Global Blood Therapeutics, Inc.

Board Member


MyoKardia Inc

Board Member


Palo Alto Investors LLC

ADVISORY BOARD Member


Board

Member


TRV GP , LLC

Managing Member


Cell Therapy News

Board Member


Konarka Technologies Inc

Board Member


Human Genome Sciences , Inc.

Board Member


The CMT Foundation

Position In Audit Committee


Shareholder.com incorporated

Board Member


Info.Resource , Inc.

Board Member


MarylandLifeScience.com

Board Member


MichiganLifeScience.com

Board Member


Utah Life Science Association

Board Member


KentuckyLifeScience.com

Board Member


ArkansasLifeScience.com

Board Member


Washington Biotechnology & Biomedical Association

Board Member


IndianaLifeScience.com

Board Member


KansasLifeScience.com

Board Member


ConnecticutLifeScience.com

Board Member


MaineLifeScience.com

Board Member


MinnesotaLifeScience.com

Board Member


HawaiiLifeScience.com

Board Member


WisconsinLifeScience.com

Board Member


IllinoisLifeScience.com

Board Member


NewYorkLifeScience.com

Board Member


FloridaLifeScience.com

Board Member


NorthCarolinaLifeScience.com

Board Member


OhioLifeScience.com

Board Member


NebraskaLifeScience.com

Board Member


MontanaLifeScience.com

Board Member


NewJerseyLifeScience.com

Board Member


AlaskaLifeScience.com

Board Member


WyomingLifeScience.com

Board Member


NewMexicoLifeScience.com

Board Member


IdahoLifeScience.com

Board Member


MassachusettsLifeScience.com

Board Member


GeorgiaLifeScience.com

Board Member


Oregon Bioscience Association

Board Member


BritishColumbiaLifeScience.com

Board Member


AlbertaLifeScience.com

Board Member


Cambridge Savings Bank

Board Member


Concurrent Pharmaceuticals , Inc.

Board Member


Faber Daeufer Itrato & Cabot

Board Member


RNA company

Board Member


VoiceSignal Technologies Inc

Board Member


Encysive Pharmaceuticals

Board Member


ColoradoLifeScience.com

Board Member


PennsylvaniaLifeScience.com

Board Member


CaliforniaLifeScience.com

Board Member


Education

BA

Brandeis University


Bachelor of Arts degree

Mathematics and Business

Colby College


M.D.


MBA

Bentley University


Master of Science degree

Corporate Finance

Boston College


Web References(116 Total References)


Panoptica | Who We Are | Board of Directors

www.panopticapharma.com [cached]

Kevin Starr
Member, Board of Directors Kevin Starr is a proven operational leader with over 25 years' experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of its portfolio companies as well as actively identifying and evaluating new investments. He also assumes active leadership roles in Third Rock portfolio companies. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led efforts to raise billions of dollars in capital through strategic alliances and public financing and drove growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. Mr. Starr holds an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College. He is a Board Member of Alnylam Pharmaceuticals and also serves on the Board of Directors for Afferent Pharmaceuticals, Agios Pharmaceuticals and Zafgen, Inc.


Our Team - SAGE Therapeutics

www.sagerx.com [cached]

Kevin Starr
Kevin is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Kevin co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. Prior to Third Rock Ventures, Kevin was Chief Operating Officer and Chief Financial Officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a Board Member of Alnylam Pharmaceuticals. Kevin holds a M.S. in Corporate Finance from Boston College and a B.A. in Mathematics and Business from Colby College.


Our People Third Rock Ventures

www.thirdrockventures.com [cached]

Kevin Starr
Partner Kevin Starr is a co-founder of Third Rock Ventures with more than 25 years of experience building and leading biotechnology companies. Kevin's focus has been on the formation, development and strategic governance of our portfolio companies. He has been actively identifying and evaluating new investments for our first three funds, where he also helped successfully raise $1.3 billion for Third Rock. Kevin contributes as an advisor to our Fund IV portfolio companies and will continue to play active board roles in our current Fund I, II and III portfolio companies. In many of these companies, Kevin functioned as chief executive officer through the first 12-18 months after launch. His portfolio company roles include: Prior to Third Rock, Kevin served as chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he helped raise billions of dollars in capital through strategic alliances and public financing and drove the company's growth through organic expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals. Kevin holds an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College. Kevin is a founding investor in Prospect Pictures, which produced the hit Broadway show turned movie "Rock of Ages." Kevin Starr Partner


Zafgen, Inc. - Definitive Proxy Statement

ir.zafgen.com [cached]

Kevin P. Starr
Director Kevin P. Starr . Mr. Starr has served as a member of our Board of Directors since December 2006. In April 2007, Mr. Starr co-founded Third Rock Ventures, a venture capital firm where he remains a partner. From January 2003 to March 2007, Mr. Starr undertook a number of entrepreneurial endeavors in the life science and entertainment industries. From December 2001 to December 2002, Mr. Starr served as chief operating officer of Millennium Pharmaceuticals, Inc. He also served as Millennium’s chief financial officer from December 1998 to December 2002. Mr. Starr currently serves on the Board of Directors of Agios Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc. and SAGE Therapeutics. Mr. Starr received an M.S. in corporate finance from Boston College and a B.S./B.A. in mathematics and business from Colby College. Mr. Starr’s qualifications to serve on our Board of Directors include his executive management roles with responsibility over key financial and business planning functions and experience in the formation, development and business strategy of multiple start-up companies in the life sciences sector. Kevin P. Starr (11) Investment decisions with respect to the shares held by TRV LP are made by an investment committee at TRV GP comprised of Mark Levin, Kevin Starr and Bob Tepper. Mr. Starr is a member of our Board of Directors. Consists of 9,356 shares of common stock Mr. Starr holds in his individual capacity, of which 1,248 shares of common stock are subject to restrictions under a Restricted Stock Agreement, which lapse over a period of one year starting January 1, 2015 on a quarterly basis in arrears. During 2014, Peter Barrett, Ph.D., John L. LaMattina, Ph.D. and Kevin P. Starr served on the compensation committee, which was chaired by John L. LaMattina, Ph.D. None of the members of our compensation committee has at any time during the last three years been one of our officers or employees or had any relationship requiring disclosure under Item 404 of Regulation S-K. Frances K. Heller, Kevin P. Starr and Frank E. Thomas serve on the audit committee, which is chaired by Frank E. Thomas. Our board has determined that while Kevin Starr satisfies the independence requirements under applicable NASDAQ Stock Market rules, he does not satisfy the independence requirements of the SEC applicable to members of audit committees. Peter Barrett, Ph.D., John L. LaMattina, Ph.D. and Kevin P. Starr serve on the compensation committee, which is chaired by John L. LaMattina, Ph.D. Peter Barrett, Ph.D. and Kevin P. Starr serve on the nominating and corporate governance committee, which is chaired by Peter Barrett, Ph.D. Kevin P. Starr Kevin P. Starr Kevin P. Starr


MyoKardia

www.myokardia.com [cached]

Kevin Starr
Co-Founder and Partner, Third Rock Ventures Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. In addition to his role at Third Rock, he also serves as the interim chief executive officer of SAGE Therapeutics. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals and SAGE Therapeutics. Mr. Starr holds a M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory